Geode Capital Management LLC Purchases 50,321 Shares of HCA Healthcare, Inc. (NYSE:HCA)

Geode Capital Management LLC raised its position in shares of HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 1.3% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 3,871,057 shares of the company's stock after acquiring an additional 50,321 shares during the period. Geode Capital Management LLC owned approximately 1.53% of HCA Healthcare worth $1,159,882,000 as of its most recent SEC filing.

Several other large investors have also made changes to their positions in HCA. Legacy Investment Solutions LLC acquired a new position in shares of HCA Healthcare during the third quarter worth approximately $39,000. Whipplewood Advisors LLC bought a new stake in HCA Healthcare in the 4th quarter valued at $31,000. Tidemark LLC bought a new position in shares of HCA Healthcare during the 4th quarter worth about $36,000. Activest Wealth Management lifted its stake in shares of HCA Healthcare by 1,250.0% in the fourth quarter. Activest Wealth Management now owns 135 shares of the company's stock valued at $40,000 after buying an additional 125 shares during the period. Finally, Pinnacle Bancorp Inc. raised its holdings in HCA Healthcare by 50.0% in the 4th quarter. Pinnacle Bancorp Inc. now owns 150 shares of the company's stock valued at $45,000 after acquiring an additional 50 shares in the last quarter. Institutional investors and hedge funds own 62.73% of the company's stock.

HCA Healthcare Trading Up 0.6 %

NYSE:HCA traded up $2.00 on Thursday, hitting $349.03. 1,946,885 shares of the stock were exchanged, compared to its average volume of 1,354,285. The company has a debt-to-equity ratio of 69.07, a quick ratio of 0.97 and a current ratio of 1.08. The stock has a market capitalization of $85.93 billion, a price-to-earnings ratio of 15.89, a P/E/G ratio of 1.10 and a beta of 1.68. The company's 50-day moving average price is $326.83 and its 200 day moving average price is $340.36. HCA Healthcare, Inc. has a 52 week low of $289.98 and a 52 week high of $417.14.

Remove Ads

HCA Healthcare (NYSE:HCA - Get Free Report) last issued its earnings results on Friday, January 24th. The company reported $6.22 EPS for the quarter, beating the consensus estimate of $6.03 by $0.19. HCA Healthcare had a net margin of 8.16% and a return on equity of 586.47%. During the same quarter in the previous year, the business posted $5.90 earnings per share. On average, equities research analysts forecast that HCA Healthcare, Inc. will post 24.98 earnings per share for the current year.

HCA Healthcare Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Monday, March 31st. Investors of record on Monday, March 17th were issued a dividend of $0.72 per share. The ex-dividend date was Monday, March 17th. This represents a $2.88 dividend on an annualized basis and a yield of 0.83%. This is a boost from HCA Healthcare's previous quarterly dividend of $0.66. HCA Healthcare's payout ratio is currently 13.11%.

Insider Transactions at HCA Healthcare

In related news, SVP Jennifer Berres sold 9,533 shares of the business's stock in a transaction that occurred on Friday, February 14th. The stock was sold at an average price of $322.59, for a total value of $3,075,250.47. Following the completion of the transaction, the senior vice president now directly owns 15,412 shares in the company, valued at approximately $4,971,757.08. The trade was a 38.22 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Insiders own 1.30% of the company's stock.

Wall Street Analyst Weigh In

A number of research analysts recently commented on the company. JPMorgan Chase & Co. restated a "neutral" rating and issued a $380.00 target price on shares of HCA Healthcare in a research note on Tuesday, December 17th. Bank of America lowered their price objective on HCA Healthcare from $380.00 to $370.00 and set a "buy" rating on the stock in a research note on Monday, January 27th. Royal Bank of Canada decreased their price target on HCA Healthcare from $405.00 to $384.00 and set an "outperform" rating on the stock in a research note on Monday, January 27th. Barclays cut their price objective on HCA Healthcare from $392.00 to $366.00 and set an "overweight" rating for the company in a report on Monday, January 27th. Finally, KeyCorp cut their price target on shares of HCA Healthcare from $420.00 to $370.00 and set an "overweight" rating for the company in a report on Tuesday, January 7th. One investment analyst has rated the stock with a sell rating, three have given a hold rating, thirteen have assigned a buy rating and two have issued a strong buy rating to the company's stock. According to MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and an average price target of $385.67.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.